Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Apr 24, 2026
Reporting period
Not applicable
Filed with the SEC
Apr 28, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001537286-26-000002
Filed / recorded
Apr 28, 2026, 10:17 PM UTC
Added to OQRO
Oct 2, 2026, 12:26 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
ABBOTT LABORATORIES
Issuer CIK
1800
Ticker
ABT
Reporting person
Sally E. Blount
Relationship
Director
Security
Common shares without par value
Table
Non-derivative (Table I)
Transaction date
Apr 24, 2026
Transaction code
A
Shares / units
2,286
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
36,344
Ownership form
Direct
Amendment
No
Footnotes from the filing
Restricted stock unit award granted under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).